Draft GMC Guidance on Cosmetic Interventions - DAC Beachcroft

Draft GMC Guidance on Cosmetic Interventions's Tags

Tags related to this article

Draft GMC Guidance on Cosmetic Interventions

Published 12 junio 2015

The General Medical Council ('GMC') has launched a public consultation on new draft Guidance which sets out the standards they expect doctors offering 'cosmetic interventions' to meet.

The Guidance will build on and incorporate principles from the GMC existing guidance for doctors, good medical practice and is expected to be published in early 2016.

The draft Guidance defines cosmetic interventions as 'any intervention, procedure (both surgical and non-surgical) or treatment carried out at the request of a patient (which also includes any person with legal authority to make a request on a patient's behalf) that has the primary objective of improving a patient's appearance'. For example surgical procedures such as face-lifts, tummy tucks and breast implants and non-surgical procedures such as dermal fillers, Botox®, use of laser or intense pulsed light (IPL) are all 'cosmetic interventions'.


The supply of cosmetic interventions in the UK generated approximately £2.3 billion in 2010, which is estimated to rise to £3.6 billion by the end of 2015. It is a rapidly expanding area and for those who practise in it the level of individual professional risk can be high, for example when working with vulnerable patients who may wish to undergo unnecessary treatments due to mental health conditions such as body dysmorphia and with young people where complex patient consent issues can arise.

In April 2013, Professor Sir Bruce Keogh KBE conducted a review of the regulations applicable to cosmetic interventions, in the wake of the Poly Implant Prothese (PIP) breast implant safety concerns which affected over 50,000 women in the UK.

The Keogh review identified the existing regulatory framework for cosmetic interventions had not kept pace with the changes in the market, and failed to provide sufficient protection against many of the potential risks arising from cosmetic intervention such as unintended muscle weakness, bleeding, scarring, burns and infection. The review called for an ethical framework to be established to support professionals supplying cosmetic interventions, to ensure high quality care is provided with the use of safe products, by skilled practitioners and responsible providers.

Key recommendations

The GMC draft Guidance addresses the Keogh review's safety concerns and in some cases sets higher standards than in the current good medical practice guidance. The key Guidance recommendations for healthcare organisations and individuals to consider at this draft stage include:

  • Making sure patients are given enough time and information before they decide whether to have a cosmetic intervention. At present the draft guidance does not specify a particular time period for this proposed "cooling off" period, as it is considered the amount of time required for each patient depends on several factors (paragraphs 20 – 27);
  • Directly seeking a patient's consent rather than delegating to another health professional (paragraph 17);
  • Taking particular care when considering requests for interventions on children and young people (paragraphs 28 – 30);
  • Considering patients' psychological needs and if necessary seeking expert advice from colleagues (paragraph 39);
  • Marketing services responsibly: Unjustifiable claims about the results should not be made and no promotional tactics are allowed which encourage people to make ill-considered decisions e.g. procedures given away as a prize (paragraphs 43, 48, 49);
  • Being open and honest with patients about the risks involved and about any financial or commercial interests that could be seen to affect the way a doctor prescribes for, advises, refers or commissions services for them (paragraph 40).

The Guidance recommendations reflect the wider changes which are occurring in the health and social care sector with the drive for greater openness, transparency and prioritisation of the patient following the recommendations made by Robert Francis QC in the Mid-Staffordshire Inquiry.

There is a need for organisations and individuals to understand the practical and cultural changes that the new Guidance will bring for those undertaking cosmetic interventions. Any serious or persistent failure to follow any GMC guidance (which will include the Guidance on cosmetic interventions once published) will put a doctor's registration at risk.

Our view

We anticipate the finalised Guidance will become pivotal for those providing cosmetic interventions, making familiarisation with the draft Guidance and responding to the consultation a priority. The consultation is open until 1st September 2015 and can be viewed on the GMC's website. We would encourage individuals and organisations to respond to the consultation.

In particular we anticipate there will be discussion regarding the draft recommendation that there will be no specified time period for a patients "cooling off" reflection time, as such a provision could create uncertainty and ambiguity both in the Guidance itself and in its implementation. This, in turn, may give risk to additional claims risk, linked to variation in practice regarding effective consent and cooling off periods.

Clinicians, organisations they are either directly employed by, or with whom they enjoy practising privileges, or those who indemnify either, will need to understand the new professional obligations when performing cosmetic interventions and associated risks.

How we can help

Our experience of healthcare organisations, the regulatory landscape and professional disciplinary proceedings enables us to support individuals, organisations and insurers by:

  • Working with them to consider the impact of the draft Guidance in all areas of their practise;
  • Assisting to complete a response to the Consultation;
  • Taking part in training and staff engagement sessions to disseminate knowledge about the impact of the new Guidance and to facilitate discussions about changes to policies and practices needed;
  • Reviewing policy and guidance documentation;
  • Identifying new risks associated with compliance.


Belinda Dix

Belinda Dix


+44 (0)1962 70 5544

< Back to articles